Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerBayer Pharmaceuticals Suspends Marketing of Trasylol
By Jamie Sheller
At the request of the FDA, Bayer Pharmaceuticals Corp. has agreed to stop marketing Trasylol. Trasylol is a drug that controls bleeding during heart surgery. According to recent studies, using Trasylol over other similar drugs significantly increases the risk of death, kidney failure, stroke or heart problems. The FDA is waiting for the results from a new study being conducted in Canada to determine if stronger measures should be taken. To read more about this topic, visit trasylol marketing
Full post as published by Philadelphia Personal Injury Lawyer on December 05, 2007 (boomark / email).
Trasylol
Bayer Faces Canadian Class Action
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Vytorin Marketing
alleged false claims in marketing campaign.
Trasylol
allegedly causing kidney and heart failure.
Acura Pharmaceuticals, Inc. ACUR Securities Fraud
Acura Pharmaceuticals, Inc. ACUR
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims

Bayer Suspends Marketing of Trasyol
Trasylol: Bayer Bracing for Lawsuits
All Trasylol Pulled from Market
Remaining Trasylol Stocks Recalled
FDA Suspends Marketing of Trasylol








